Top View
- Chemical Disarming of Isoniazid Resistance in Mycobacterium Tuberculosis
- IC50 Determination V
- A Two-Point IC50 Method for Evaluating the Biochemical Potency of Irreversible Enzyme Inhibitors
- Cytotoxicity: in Vitro Determination
- Protocol-Dependent Differences in IC50 Values Measured in Herg Assays Occur in A
- Mechanism of Action: Characterization of Enzyme-Inhibitor Interactions Using Microfluidic Mobility-Shift Assays Abbie L
- Evaluation of P-Glycoprotein Inhibitory Potential Using a Rhodamine 123 Accumulation Assay
- Evaluation of IC50 Levels Immediately After Treatment with Anticancer Reagents Using a Real‑Time Cell Monitoring Device
- Antimycobacterial and Cytotoxicity Activities of Free and Liposome-Encapsulated 3-(4'-Bromo [1, 1'-Biphenyl-4-Yl)-3-(4-Bromo-Phenyl)-N, N-Dimethyl-2-Propen-1-Amine
- In Vitro Prevention of the Emergence of Multidrug Resistance in a Pediatric Rhabdomyosarcoma Cell Line1
- Preclinical in Vivo Evaluation of Efficacy, Pharmacokinetics, and Pharmacodynamics of a Novel MEK1/2 Kinase Inhibitor RO5068760 in Multiple Tumor Models
- The Reliability of Estimating Ki Values for Direct, Reversible Inhibition Of
- Arxiv:1701.03702V1 [Q-Bio.CB] 13 Jan 2017 Medium [8] and the Presence of Other Antibiotics [12]
- Pharmacology of Acid-Sensing Ion Channels – Physiological and Therapeutical Perspectives Anne Baron, Eric Lingueglia
- 1 Supplementary Table 1. Specificity of NMDAR Antagonists Drug Target
- Antibacterial and Antitubercular Activities of Cinnamylideneacetophenones
- Oecd Guideline for the Testing of Chemicals
- Strain-Specific Anti-Biofilm and Antibiotic-Potentiating Activity of 3′,4
- Potency, Selectivity, and Consequences of Nonselectivity of PDE Inhibition
- IC50 Vs Human LC
- Quantitative Evaluation of the Antiretroviral Efficacy of Dolutegravir
- Guidance Document on Using in Vitro Data to Estimate in Vivo Starting Doses for Acute Toxicity
- The Role of Pharmacokinetics and Pharmacodynamics in Phosphodiesterase-5 Inhibitor Therapy
- Inhibition of Tetramethylpyrazine on P-Gp, MRP2, MRP3 and MRP5 in Multidrug Resistant Human Hepatocellular Carcinoma Cells
- Dose–Response Curve Slope Is a Missing Dimension in the Analysis of HIV-1 Drug Resistance
- Discovery of a Highly Potent Novel Rifampicin Analog by Preparing A
- Response Curve Slope Helps Predict Therapeutic Potency and Breadth of HIV Broadly Neutralizing Antibodies
- A Statistical Framework for Assessing Pharmacological Responses And
- Memantine and Ketamine Differentially Alter NMDA Receptor Desensitization
- The Cytotoxicity Effect of Resveratrol: Cell Cycle Arrest and Induced
- In Vitro and in Vivo Pharmacodynamics of Three Novel Antileishmanial Lead T Series
- Determination of in Vivo Toxicity and in Vitro Cytotoxicity of Venom from the Cypriot Blunt-Nosed Viper Macrovipera Lebetina
- Pharmacology of Novel Psychoactive Substances
- Overcoming Multidrug Resistance in Human Lung Cancer with Novel Benzo[A]Quinolizin-4-Ones
- Synthesis and Bioactivity of Thiazolethioacetamides As Potential Metallo-Β-Lactamase Inhibitors
- 4875.Full.Pdf
- Clinical Pharmacokinetics Preferred Symbols
- Inhibiting the NLRP3 Inflammasome
- Phthalascidin, a Synthetic Antitumor Agent with Potency and Mode of Action Comparable to Ecteinascidin 743
- Why IC50's Are Bad For
- Phytochemical Constituents, Antioxidant, Cytotoxic, and Antimicrobial Activities of the Ethanolic Extract of Mexican Brown Propolis
- How Reliable Are in Vitro IC50 Values? Values Vary with Cytotoxicity Assays in Human Glioblastoma Cells